Research unit
Project number
103.243.1 IP-LS
Project title
Developing the first effective targeted therapy for the aggressive NRAS melanoma subtype
Project status In Process
Start date 01.05.2023
End date 01.11.2024
Granted total costs 559'338.00  CHF
Section 60 Life Sciences
Project category Project
Research type Applied research and development
NABS classification Industrial production and technology
Research disciplines
100 % B007 Medicine (human and vertebrates)

Last modification of the project